Tdap Vaccination for Infant Caregivers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01233401
Recruitment Status : Completed
First Posted : November 3, 2010
Last Update Posted : July 28, 2011
Saint Raphael Healthcare System
Information provided by:
Yale University

November 1, 2010
November 3, 2010
July 28, 2011
June 2010
December 2010   (Final data collection date for primary outcome measure)
Maternal Tdap Vaccination Rate [ Time Frame: At 2 week well child visit ]
Same as current
Complete list of historical versions of study NCT01233401 on Archive Site
Other Infant Caregiver Tdap Vaccination Rate [ Time Frame: At 2 week well child visit ]
Same as current
Not Provided
Not Provided
Tdap Vaccination for Infant Caregivers
Tdap Vaccination for Infant Caregivers in the Pediatric Office
This study evaluates whether offering Tetanus, diphteria and acellular pertussis (Tdap) vaccine to caregivers of newborn infants during pediatric well child visits increase the caregivers' vaccination rates.
Not Provided
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample
18-64 year old men and women who are mothers or other infant caregivers of 2 week old infants
  • Pertussis
  • Vaccination
Other: Survey
Mothers and Other infant caregivers are surveyed at the end of the 2 week newborn well child visit about whether they chose to receive the Tdap vaccine at the pediatrician's office.
  • Mothers
    Intervention: Other: Survey
  • Other Infant Caregivers
    Includes fathers, grandparents, and other adults who are infant caregivers
    Intervention: Other: Survey
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
June 2011
December 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • 18-64 years old
  • English or Spanish speaking

Exclusion Criteria:

  • Do not speak English or Spanish
Sexes Eligible for Study: All
18 Years to 64 Years   (Adult)
Contact information is only displayed when the study is recruiting subjects
United States
Not Provided
Not Provided
Deepa Camenga, MD, Yale University
Yale University
Saint Raphael Healthcare System
Principal Investigator: Deepa R Camenga, MD Yale University
Principal Investigator: Marjorie Rosenthal, MD MPH Yale University
Yale University
July 2011